ALMS1 and myocardial infarction: For instance, ALMS1 is considered a biomarker for the diagnosis and prognosis of acute myocardial infarction (AMI) [84], with specific variants, such as G/A variant (rs674804) and glutamic acid repeat polymorphism, being markers for early-onset myocardial infarction [85,86].